These results suggest that triple-negative breast cancer cell proliferation is not leptin-dependent and that in highly invasive mesenchymal cells with a claudin-low profile, such as MDA-MB-231 cells, survival depends on basal autophagy in control or leptin-treated conditions. The gene discussed is LEP; the disease is triple-negative breast carcinoma.